Barbara Körber-Irrgang

Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)

Xenia Schleicher, Paul G. Higgins, Hilmar Wisplinghoff et al. · Clinical Microbiology and Infection · 2012 · 81 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

<i>In Vitro</i> Spectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions

Will Stubbings, Pamela Leow, Goh Chee Yong et al. · Antimicrobial Agents and Chemotherapy · 2011 · 72 citations · Full text

Medicine, Microbiology, Pharmacology +14

Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries

Michael Kresken, Barbara Körber-Irrgang, Douglas J. Biedenbach et al. · Clinical Microbiology and Infection · 2015 · 58 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: Extended-spectrum β-lactamases and the role of fosfomycin

Michael Kresken, Yvonne Pfeifer, D. Häfner et al. · International Journal of Antimicrobial Agents · 2014 · 48 citations

Life Sciences, Infectious Diseases, Microbiology +17

Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany

Michael Kresken, Barbara Körber-Irrgang, Miriam Korte-Berwanger et al. · International Journal of Antimicrobial Agents · 2020 · 34 citations

Life Sciences, Infectious Diseases, Microbiology +12